{"id":"https://openalex.org/W2906258505","doi":"https://doi.org/10.1182/blood-2018-99-120269","title":"Systems Biology Analysis Identifies Targetable Vulnerability Networks to Proteasome Inhibitors in Multiple Myeloma","display_name":"Systems Biology Analysis Identifies Targetable Vulnerability Networks to Proteasome Inhibitors in Multiple Myeloma","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2906258505","doi":"https://doi.org/10.1182/blood-2018-99-120269","mag":"2906258505"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-120269","doi":"https://doi.org/10.1182/blood-2018-99-120269","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-120269","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014350127","display_name":"Mark B. Meads","orcid":"https://orcid.org/0009-0008-0259-1875","observed_orcids":["https://orcid.org/0009-0008-0259-1875"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark B. Meads","raw_affiliation_strings":["12902 Magnolia Drive, H. Lee Moffitt Cancer Center & Research Institute, Tampa,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12902 Magnolia Drive, H. Lee Moffitt Cancer Center & Research Institute, Tampa,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060845150","display_name":"Rafael Renatino Canevarolo","orcid":"https://orcid.org/0000-0002-8722-8512","observed_orcids":["https://orcid.org/0000-0002-8722-8512"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rafael Renatino Canevarolo","raw_affiliation_strings":["Moffitt Cancer Center, Tampa,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012307401","display_name":"Praneeth Reddy Sudalagunta","orcid":"https://orcid.org/0000-0003-1283-9332","observed_orcids":["https://orcid.org/0000-0003-1283-9332"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Praneeth Reddy Sudalagunta","raw_affiliation_strings":["Cancer Imaging and Metabolism, H Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Imaging and Metabolism, H Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Paula S. Oliveira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Paula S. Oliveira","raw_affiliation_strings":["Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077383203","display_name":"Dario M. Magaletti","orcid":"https://orcid.org/0009-0005-2371-9290","observed_orcids":["https://orcid.org/0009-0005-2371-9290"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Dario M. Magaletti","raw_affiliation_strings":["Moffitt Cancer Center, Tampa,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076672524","display_name":"Bin Fang","orcid":"https://orcid.org/0000-0002-7636-1318","observed_orcids":["https://orcid.org/0000-0002-7636-1318","https://orcid.org/0000-0003-0506-2932"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Bin Fang","raw_affiliation_strings":["Proteomics and Metabolomics Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Proteomics and Metabolomics Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Maria D Coelho Siqueira Silva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Maria D Coelho Siqueira Silva","raw_affiliation_strings":["Cancer Imaging and Metabolism, H Lee Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Imaging and Metabolism, H Lee Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079103673","display_name":"Amit Kulkarni","orcid":"https://orcid.org/0009-0000-4624-4789","observed_orcids":["https://orcid.org/0009-0000-4624-4789"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Amit Kulkarni","raw_affiliation_strings":["M2GEN, TAMPA, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M2GEN, TAMPA, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101790056","display_name":"Hongyue A. Dai","orcid":"https://orcid.org/0000-0002-6609-9141","observed_orcids":["https://orcid.org/0000-0002-6609-9141"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Hongyue Dai","raw_affiliation_strings":["M2Gen, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M2Gen, Tampa, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103061547","display_name":"William S. Dalton","orcid":"https://orcid.org/0000-0001-9417-2599","observed_orcids":["https://orcid.org/0000-0001-9417-2599"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William S. Dalton","raw_affiliation_strings":["M2Gen, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M2Gen, Tampa, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047091186","display_name":"Ion Petre","orcid":"https://orcid.org/0000-0002-5014-5529","observed_orcids":["https://orcid.org/0000-0002-5014-5529"]},"institutions":[{"id":"https://openalex.org/I130217899","display_name":"\u00c5bo Akademi University","ror":"https://ror.org/029pk6x14","country_code":"FI","type":"education","lineage":["https://openalex.org/I130217899"]}],"countries":["FI"],"is_corresponding":true,"raw_author_name":"Ion Petre","raw_affiliation_strings":["ABO AKADEMI, Agora, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ABO AKADEMI, Agora, Finland","institution_ids":["https://openalex.org/I130217899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002876951","display_name":"John M. Koomen","orcid":"https://orcid.org/0000-0002-3818-1762","observed_orcids":["https://orcid.org/0000-0002-3818-1762"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John M. Koomen","raw_affiliation_strings":["Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070118399","display_name":"Ariosto Siqueira Silva","orcid":"https://orcid.org/0000-0003-3237-9986","observed_orcids":["https://orcid.org/0000-0003-3237-9986"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ariosto Siqueira Silva","raw_affiliation_strings":["Moffitt Cancer Center, Tampa,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053572690","display_name":"Kenneth H. Shain","orcid":"https://orcid.org/0000-0003-4178-8888","observed_orcids":["https://orcid.org/0000-0003-4178-8888"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth H. Shain","raw_affiliation_strings":["Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5002876951","https://openalex.org/A5012307401","https://openalex.org/A5014350127","https://openalex.org/A5047091186","https://openalex.org/A5060845150","https://openalex.org/A5070118399","https://openalex.org/A5076672524","https://openalex.org/A5077383203","https://openalex.org/A5079103673","https://openalex.org/A5101790056"],"corresponding_institution_ids":["https://openalex.org/I130217899","https://openalex.org/I3019308854"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"950","last_page":"950"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9789999723434448},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.9440000057220459},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.8799999952316284},{"id":"https://openalex.org/keywords/carfilzomib","display_name":"carfilzomib","score":0.9929999709129333},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.9139999747276306},{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.8199999928474426},{"id":"https://openalex.org/keywords/protein-protein-interaction-network","display_name":"protein-protein interaction network","score":0.8009999990463257},{"id":"https://openalex.org/keywords/transcription-factors","display_name":"transcription factors","score":0.6480000019073486},{"id":"https://openalex.org/keywords/kinase-profiling","display_name":"kinase profiling","score":0.515999972820282},{"id":"https://openalex.org/keywords/activity-based-protein-profiling","display_name":"activity-based protein profiling","score":0.7670000195503235},{"id":"https://openalex.org/keywords/gene-expression-clustering","display_name":"gene expression clustering","score":0.3889999985694885},{"id":"https://openalex.org/keywords/relapsed-multiple-myeloma","display_name":"relapsed multiple myeloma","score":0.7390000224113464},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.3799999952316284}],"concepts":[{"id":"https://openalex.org/C54174078","wikidata":"https://www.wikidata.org/wiki/Q3197188","display_name":"Kinome","level":3,"score":0.8385634422302246},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.7082844972610474},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6514891386032104},{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.5930406451225281},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5220791697502136},{"id":"https://openalex.org/C2778524551","wikidata":"https://www.wikidata.org/wiki/Q7227206","display_name":"Pomalidomide","level":4,"score":0.521195113658905},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.5174558758735657},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.49604615569114685},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.4758013188838959},{"id":"https://openalex.org/C18431079","wikidata":"https://www.wikidata.org/wiki/Q1502169","display_name":"Gene expression profiling","level":4,"score":0.46654200553894043},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4261779189109802},{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.424567848443985},{"id":"https://openalex.org/C166703698","wikidata":"https://www.wikidata.org/wiki/Q201993","display_name":"RNA interference","level":4,"score":0.4220763146877289},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3711344003677368},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.344401478767395},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.3388913571834564},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.23484936356544495},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16914421319961548},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.1006212830543518}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-120269","doi":"https://doi.org/10.1182/blood-2018-99-120269","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-120269","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2910219881","https://openalex.org/W4405050138","https://openalex.org/W2986338442","https://openalex.org/W3211893567","https://openalex.org/W2344709855","https://openalex.org/W4310125461","https://openalex.org/W4385983350","https://openalex.org/W2915924992","https://openalex.org/W4249130316","https://openalex.org/W2405000124"],"abstract_inverted_index":{"Abstract":[0],"Proteasome":[1],"inhibitors":[2,70,449],"(PI)":[3],"such":[4],"as":[5,564,592],"bortezomib":[6],"and":[7,32,68,76,92,116,135,153,184,195,214,227,236,244,267,287,323,347,349,359,372,387,410,422,454,478,491,501,531,547,557,568,606,639],"carfilzomib":[8,496,523],"are":[9],"critical":[10,595,628],"components":[11],"of":[12,85,191,277,280,291,294,384,389,468,524,544,602,634,643,652],"anti-multiple":[13],"myeloma":[14,40,328],"(MM)":[15],"therapy,":[16],"yet":[17],"all":[18,525],"MM":[19,47,197,223,285,299,366,385,391,436,511,597],"patients":[20,589],"eventually":[21],"develop":[22],"refractory":[23,510],"disease.":[24],"We":[25,619],"developed":[26],"a":[27,147,256,278,292,331,443,540,565,593,608,627],"non-biased":[28],"method":[29],"to":[30,66,81,100,126,138,170,203,272,309,450,576,596,611,636,654],"identify":[31,82,101,127,273],"validate":[33],"dysregulated":[34],"pathways":[35],"associated":[36,150,206],"with":[37,61,103,109,151,207,230,463,495,522,583],"PI-resistance":[38,152,208],"in":[39,89,117,162,177,186,240,283,297,326,355,363,425,435,460,497,508,528,535,537,561,599,646],"by":[41,218,252,305,379,401,442],"combining":[42],"RNAseq":[43],"data":[44,587,623],"from":[45,51,181,588],"522":[46],"patient":[48,426,437,461,499,529],"specimens":[49,180,386,440,462,500,530],"obtained":[50],"our":[52,163],"Total":[53],"Cancer":[54,59],"Care/M2Gen/ORIEN":[55],"network":[56],"at":[57],"Moffitt":[58],"Center":[60],"paired":[62,192],"ex":[63,505],"vivo":[64,187,381,506,538],"sensitivity":[65,383],"PIs":[67],"kinase":[69],"(KI).":[71],"Dimensionality":[72],"reduction":[73],"analysis":[74],"(t-SNE)":[75],"Fuzzy":[77],"C-means":[78],"was":[79,98,518,532,569],"used":[80,99],"422":[83],"clusters":[84,102],"genes":[86],"that":[87,107,166,301,337,615,621],"co-express":[88],"individual":[90],"patients,":[91,183],"Gene":[93],"Set":[94],"Enrichment":[95],"Analysis":[96],"(GSEA)":[97],"gene":[104,585],"expression":[105,586],"patterns":[106],"correlated":[108],"PI":[110,140,382,545,604],"sensitivity.":[111],"Using":[112],"publicly":[113],"curated":[114],"databases":[115],"silico":[118],"integrative":[119],"analyses,":[120],"we":[121,175],"built":[122],"protein-protein":[123],"interaction":[124],"networks":[125],"putative":[128],"transcription":[129],"factors,":[130],"corresponding":[131],"master":[132],"regulators":[133],"(kinases),":[134],"candidate":[136],"KIs":[137,343,413,484,526],"promote":[139],"sensitization.":[141],"This":[142],"systems":[143],"biology":[144],"approach":[145],"identified":[146,378,400,424,590],"Chk1-Cdk1-Plk1":[148],"circuit":[149],"also":[154,625],"found":[155],"21":[156],"additional":[157],"kinases":[158,205,275,289,314,375,398],"(of":[159],"501":[160],"expressed":[161],"cohort's":[164],"kinome)":[165],"could":[167],"be":[168],"targeted":[169],"re-sensitize":[171],"PI-resistant":[172,194,319,327,365,573],"MM,":[173],"which":[174,515],"confirmed":[176],"cell":[178,198,224,311,320,367,392],"lines,":[179],"relapsed":[182,509],"two":[185,536],"models.":[188],"A":[189],"panel":[190],"isogenic":[193],"sensitive":[196],"lines":[199,225,329],"were":[200,238,246,261,302,315,324,377,399,493],"differentially":[201],"screened":[202,325],"find":[204,612],"using":[209,263,330],"activity-based":[210],"protein":[211],"profiling":[212],"(ABPP)":[213],"KI":[215],"activity":[216,434,459,507],"measured":[217,262],"high-throughput":[219],"viability":[220,335],"assay.":[221],"The":[222],"8226":[226],"U266,":[228],"along":[229],"their":[231],"drug":[232],"resistant":[233],"counterparts":[234],"8226-B25":[235,284],"U266-PR,":[237,370],"grown":[239],"mono-culture":[241],"for":[242,248,630],"24h":[243],"lysates":[245],"enriched":[247,304],"ATP":[249],"binding":[250],"proteins":[251,282,296],"affinity":[253,445],"purification":[254],"versus":[255,572],"chemical":[257],"probe.":[258],"Tryptic":[259],"peptides":[260],"discovery":[264],"proteomics":[265],"(nano-UPLC":[266],"QExactive":[268],"Plus":[269],"mass":[270],"spectrometer)":[271],"85":[274],"out":[276,290],"total":[279,293],"715":[281],"cells":[286,300],"35":[288],"688":[295],"U266-PR":[298],"preferentially":[303],"2-fold":[306],"change":[307],"compared":[308,575],"parental":[310],"lines.":[312],"Twenty-four":[313,374],"commonly":[316],"activated":[317],"among":[318],"line":[321,393],"pairs":[322],"label-free,":[332],"high":[333],"throughput":[334],"assay":[336],"simulates":[338],"the":[339,356,457,519,548,600,631,641],"tumor":[340,559,613],"microenvironment.":[341],"Three":[342],"targeting":[344,414,485],"Plk1":[345,455,591],"(volasertib":[346],"GSK461364)":[348],"Cdk1/5":[350],"(dinaciclib)":[351],"consistently":[352],"maintained":[353,502],"LD50s":[354],"low-nanomolar":[357],"range":[358],"induced":[360],"caspase-3":[361],"activation":[362],"four":[364],"lines:":[368],"8226-B25,":[369],"ANBL-6-V10R,":[371],"Kas6-V10R.":[373],"each":[376],"RNAseq/ex":[380],"ABPP":[388],"PI-resistant/sensitive":[390],"pairs.":[394],"Of":[395],"these,":[396,448],"7":[397],"both":[402,562],"methods:":[403],"Cdk1,":[404,415,451],"Chk1,":[405],"Plk1,":[406,416,486,517],"ILK,":[407,417,452,487],"Syk,":[408,419,488],"PKA,":[409],"p70S6K.":[411],"Several":[412],"DNAPK,":[418],"MKK7,":[420,489],"Nek2,":[421],"mTOR":[423],"specimen":[427],"or":[428,503],"cell-line":[429],"screens":[430],"showed":[431,456],"single":[432,566],"agent":[433],"bone":[438],"marrow":[439],"purified":[441],"CD138":[444],"column.":[446],"Among":[447],"mTOR,":[453],"most":[458,520],"an":[464],"average":[465],"96h":[466],"LD50":[467],"25":[469],"nM":[470],"(n=56),":[471],"2.4":[472],"uM":[473,476,480],"(n=42),":[474],"2.7":[475],"(n=57)":[477],"3.8":[479],"(n=53),":[481],"respectively.":[482],"Six":[483],"Nek2":[490],"MARK3":[492],"synergistic":[494,521],"20":[498],"improved":[504],"(RRMM)":[512],"specimens.":[513],"Volasertib,":[514],"targets":[516],"tested":[527],"further":[533],"validated":[534],"models:":[539],"NSG/U266":[541],"xenograft":[542],"model":[543],"resistance":[546,605],"syngeneic":[549],"C57BL/6-KaLwRij/5TGM1":[550],"immunocompetent":[551],"model.":[552],"Volasertib":[553],"significantly":[554],"increased":[555],"survival":[556,598],"reduced":[558],"burden":[560],"models":[563],"agent,":[567],"more":[570],"effective":[571],"tumors":[574],"PI-sensitive":[577],"counterparts.":[578],"Our":[579],"pharmaco-proteomic":[580],"screen,":[581],"coupled":[582],"rich":[584],"target":[594],"context":[601],"acquired":[603],"represents":[607],"unique":[609],"workflow":[610],"vulnerabilities":[614],"arise":[616],"during":[617],"therapy.":[618],"anticipate":[620],"these":[622],"will":[624],"produce":[626],"path":[629],"personalized":[632],"allocation":[633],"therapy":[635],"maximize":[637],"efficacy":[638],"minimize":[640],"use":[642],"ineffective":[644],"therapies":[645],"RRMM.":[647],"Disclosures":[648],"No":[649],"relevant":[650],"conflicts":[651],"interest":[653],"declare.":[655]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2019-01-01T00:00:00"}